Association Between Medicaid Coverage Continuity and Survival in Patients With Newly Diagnosed Pediatric and Adolescent Cancers.

IF 4.7 3区 医学 Q1 ONCOLOGY JCO oncology practice Pub Date : 2024-09-30 DOI:10.1200/OP.24.00268
Xin Hu, Sharon M Castellino, Anne C Kirchhoff, Rebecca S Williamson Lewis, Nicholas P DeGroote, Patricia Cornwell, Ann C Mertens, Joseph Lipscomb, Xu Ji
{"title":"Association Between Medicaid Coverage Continuity and Survival in Patients With Newly Diagnosed Pediatric and Adolescent Cancers.","authors":"Xin Hu, Sharon M Castellino, Anne C Kirchhoff, Rebecca S Williamson Lewis, Nicholas P DeGroote, Patricia Cornwell, Ann C Mertens, Joseph Lipscomb, Xu Ji","doi":"10.1200/OP.24.00268","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Many patients with cancer do not gain Medicaid coverage until a cancer diagnosis, which can reduce access to early cancer detection and timely treatment, potentially driving inferior survival. Little is known about whether continuous Medicaid coverage prediagnosis through postdiagnosis (<i>v</i> gaining Medicaid at/after diagnosis) provides survival benefits for pediatric/adolescent oncology patients.</p><p><strong>Materials and methods: </strong>We identified patients newly diagnosed with cancer at age 21 years or younger in a large pediatric health system between 2007 and 2016. Electronic medical records (EMRs) were linked to Medicaid administrative data to differentiate insurance continuity patterns during the 6 months preceding through the 6 months after cancer diagnosis (assessment window): continuous Medicaid, newly gained Medicaid (at or after diagnosis), and other Medicaid enrollment patterns. For patients not linked to Medicaid data, we used EMR-reported insurance types at diagnosis. We followed patients from 6 months postdiagnosis up to 5 years, death, or December 2020, whichever came first. Multivariable regressions estimated all-cause and cancer-specific survival, controlling for sociodemographic and cancer-related factors.</p><p><strong>Results: </strong>Among 1,800 patients included in the analysis, 1,293 (71.8%) had some Medicaid enrollment during the assessment window; among them, 47.6% had continuous Medicaid and 36.3% had newly gained Medicaid. Patients not linked with Medicaid data had private (26.9%) or other/no insurance (1.2%) at diagnosis. Compared with patients with continuous Medicaid, those with newly gained Medicaid had higher risks of all-cause death (hazard ratio [HR], 1.41 [95% CI, 1.10 to 1.81]; <i>P</i> = .008) and cancer-specific death (HR, 1.46 [95% CI, 1.12 to 1.90]; <i>P</i> = .005).</p><p><strong>Conclusion: </strong>Continuous Medicaid coverage throughout cancer diagnosis is associated with survival benefits for pediatric/adolescent patients. This finding has critical implications as millions of American individuals have been losing coverage since the unwinding of the Medicaid Continuous Enrollment Provision.</p>","PeriodicalId":14612,"journal":{"name":"JCO oncology practice","volume":" ","pages":"OP2400268"},"PeriodicalIF":4.7000,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JCO oncology practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1200/OP.24.00268","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Many patients with cancer do not gain Medicaid coverage until a cancer diagnosis, which can reduce access to early cancer detection and timely treatment, potentially driving inferior survival. Little is known about whether continuous Medicaid coverage prediagnosis through postdiagnosis (v gaining Medicaid at/after diagnosis) provides survival benefits for pediatric/adolescent oncology patients.

Materials and methods: We identified patients newly diagnosed with cancer at age 21 years or younger in a large pediatric health system between 2007 and 2016. Electronic medical records (EMRs) were linked to Medicaid administrative data to differentiate insurance continuity patterns during the 6 months preceding through the 6 months after cancer diagnosis (assessment window): continuous Medicaid, newly gained Medicaid (at or after diagnosis), and other Medicaid enrollment patterns. For patients not linked to Medicaid data, we used EMR-reported insurance types at diagnosis. We followed patients from 6 months postdiagnosis up to 5 years, death, or December 2020, whichever came first. Multivariable regressions estimated all-cause and cancer-specific survival, controlling for sociodemographic and cancer-related factors.

Results: Among 1,800 patients included in the analysis, 1,293 (71.8%) had some Medicaid enrollment during the assessment window; among them, 47.6% had continuous Medicaid and 36.3% had newly gained Medicaid. Patients not linked with Medicaid data had private (26.9%) or other/no insurance (1.2%) at diagnosis. Compared with patients with continuous Medicaid, those with newly gained Medicaid had higher risks of all-cause death (hazard ratio [HR], 1.41 [95% CI, 1.10 to 1.81]; P = .008) and cancer-specific death (HR, 1.46 [95% CI, 1.12 to 1.90]; P = .005).

Conclusion: Continuous Medicaid coverage throughout cancer diagnosis is associated with survival benefits for pediatric/adolescent patients. This finding has critical implications as millions of American individuals have been losing coverage since the unwinding of the Medicaid Continuous Enrollment Provision.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
新确诊的儿童和青少年癌症患者的医疗补助覆盖连续性与存活率之间的关系》(Medicaid Coverage Continuity and Survival in Patients with Newly Diagnosed Pediatric and Adolescent Cancers)。
目的:许多癌症患者在确诊癌症之前并没有获得医疗补助保险,这可能会减少早期癌症检测和及时治疗的机会,从而降低生存率。至于在诊断前到诊断后持续享受医疗补助(即在诊断时/后获得医疗补助)是否会为儿科/青少年肿瘤患者带来生存方面的益处,人们知之甚少:我们确定了 2007 年至 2016 年间在一个大型儿科医疗系统中新确诊的 21 岁或以下癌症患者。电子病历(EMR)与医疗补助(Medicaid)管理数据相链接,以区分癌症诊断前 6 个月至诊断后 6 个月(评估窗口)期间的保险连续性模式:连续医疗补助、新获得的医疗补助(诊断时或诊断后)以及其他医疗补助注册模式。对于未链接到医疗补助计划数据的患者,我们使用 EMR 报告的诊断时的保险类型。我们对患者进行了从诊断后 6 个月到 5 年、死亡或 2020 年 12 月(以先到者为准)的随访。多变量回归估算了全因生存率和癌症特异性生存率,并对社会人口学因素和癌症相关因素进行了控制:在纳入分析的 1,800 名患者中,1,293 人(71.8%)在评估窗口期间加入了一些医疗补助计划;其中 47.6% 持续加入了医疗补助计划,36.3% 新加入了医疗补助计划。未与医疗补助计划数据关联的患者在确诊时拥有私人保险(26.9%)或其他/无保险(1.2%)。与连续享受医疗补助的患者相比,新获得医疗补助的患者全因死亡风险更高(危险比 [HR],1.41 [95% CI,1.10 至 1.81];P = .008),癌症特异性死亡风险更高(HR,1.46 [95% CI,1.12 至 1.90];P = .005):结论:在癌症诊断期间持续享受医疗补助与儿童/青少年患者的生存益处相关。这一发现具有重要意义,因为自医疗补助连续参保规定解除以来,已有数百万美国人失去了医保。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.40
自引率
7.50%
发文量
518
期刊最新文献
Clinical Relevance of Intensive Laboratory Monitoring With Standard Venetoclax Ramp-Up for Chronic Lymphocytic Leukemia: A Real-World Experience. Evaluation of the Impact of Monitoring for Tumor Lysis During Venetoclax Ramp-Up in Chronic Lymphocytic Leukemia in Routine Clinical Practice. Management of Stage III Non-Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update Clinical Insights. Pregnancy-Associated Breast Cancer: Key Concepts for Optimizing Diagnosis and Treatment. Did I Mess Up Today?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1